What does Bioresolutions do?

Bioresolutions is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 1 December 2020, 1 establishment.

What is the address of Bioresolutions?

The registered office of Bioresolutions is located at Kruishoutemstraat 57, 9870 Zulte.

Is Bioresolutions still active?

Yes. According to the CBE (30 October 2026) Bioresolutions is active, legal situation “Normale toestand”, started on 1 December 2020.

Is Bioresolutions registered on Peppol?

Yes, Bioresolutions is registered on the Peppol network with ID 0208:0758934037.

What is the enterprise number of Bioresolutions?

The enterprise number of Bioresolutions is BE0758934037.

When was Bioresolutions founded?

Bioresolutions was founded on 1 December 2020.

Who are the directors of Bioresolutions?

According to the 2025 annual accounts, the directors of Bioresolutions are: JOKE VANDESOMPELE, ELLEN LEFEBVRE.

Is Bioresolutions a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2020; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Bioresolutions make in 2025?

Bioresolutions recorded a loss after taxes of € 4,068 in financial year 2025.

What is the revenue of Bioresolutions?

As a small company, Bioresolutions is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 159.

Bioresolutions (Private Limited) - Zulte - BE0758934037

Dossier Bioresolutions, printed on 30 October 2026 from databakkes.be/en/0758934037/bioresolutions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Bioresolutions from Zulte, company number BE0758934037, closed financial year 2025 with a result of € -4,068 after tax. For that financial year Bioresolutions recorded a gross margin of € 159 and equity of € 213,564. Compared with financial year 2024, the result moved from € -8,042 to € -4,068. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 213,564

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,068

▲ 49 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,035

▼ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 202,564.

People and assets in 2025

Vehicles and equipment

€ 12,907

▲ 164% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 673

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 165

▼ 86% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 93,560 Gross margin 2022: € 93,560 First fiscal year in the series	€ 5,837 Gross margin 2023: € 5,837 ▼ 94% vs 2022 (€ 93,560) Unfavourable step	€ -5,491 Gross margin 2024: € -5,491 ▼ € 11,328 vs 2023 (€ 5,837) Unfavourable step	€ 159 Gross margin 2025: € 159 ▲ € 5,650 vs 2024 (€ -5,491) Favourable step	▲ € 5,650
Profit after taxes	€ 71,756 Profit after taxes 2022: € 71,756 First fiscal year in the series	€ 521 Profit after taxes 2023: € 521 ▼ 99% vs 2022 (€ 71,756) Unfavourable step	€ -8,042 Profit after taxes 2024: € -8,042 ▼ € 8,563 vs 2023 (€ 521) Unfavourable step	€ -4,068 Profit after taxes 2025: € -4,068 ▲ € 3,974 vs 2024 (€ -8,042) Favourable step	▲ € 3,974
Equity	€ 245,153 Equity 2022: € 245,153 First fiscal year in the series	€ 245,674 Equity 2023: € 245,674 Unchanged (€ 245,153) Favourable step	€ 237,632 Equity 2024: € 237,632 ▼ 3% vs 2023 (€ 245,674) Unfavourable step	€ 213,564 Equity 2025: € 213,564 ▼ 10% vs 2024 (€ 237,632) Unfavourable step	▼ 10%
Total debts	€ 42,397 Total debts 2022: € 42,397 First fiscal year in the series	€ 10,243 Total debts 2023: € 10,243 ▼ 76% vs 2022 (€ 42,397) Favourable step	€ 4,739 Total debts 2024: € 4,739 ▼ 54% vs 2023 (€ 10,243) Favourable step	€ 6,052 Total debts 2025: € 6,052 ▲ 28% vs 2024 (€ 4,739) Unfavourable step	▲ 28%
Cash	€ 258,636 Cash 2022: € 258,636 First fiscal year in the series	€ 187,755 Cash 2023: € 187,755 ▼ 27% vs 2022 (€ 258,636) Unfavourable step	€ 82,162 Cash 2024: € 82,162 ▼ 56% vs 2023 (€ 187,755) Unfavourable step	€ 27,035 Cash 2025: € 27,035 ▼ 67% vs 2024 (€ 82,162) Unfavourable step	▼ 67%
Retained profit	€ 234,153 Retained profit 2022: € 234,153 First fiscal year in the series	€ 234,674 Retained profit 2023: € 234,674 Unchanged (€ 234,153) Favourable step	€ 226,632 Retained profit 2024: € 226,632 ▼ 3% vs 2023 (€ 234,674) Unfavourable step	€ 202,564 Retained profit 2025: € 202,564 ▼ 11% vs 2024 (€ 226,632) Unfavourable step	▼ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 20,000 Dividend 2025: € 20,000 Unchanged (€ 0) Unchanged
Bank debt	€ 20 Bank debt 2022: € 20 First fiscal year in the series	€ 928 Bank debt 2023: € 928 ▲ € 908 vs 2022 (€ 20) Unfavourable step	€ 17 Bank debt 2024: € 17 ▼ 98% vs 2023 (€ 928) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 17) Favourable step	▼ 100%
Balance sheet total	€ 287,551 Balance sheet total 2022: € 287,551 First fiscal year in the series	€ 255,918 Balance sheet total 2023: € 255,918 ▼ 11% vs 2022 (€ 287,551) Unchanged	€ 242,371 Balance sheet total 2024: € 242,371 ▼ 5% vs 2023 (€ 255,918) Unchanged	€ 219,616 Balance sheet total 2025: € 219,616 ▼ 9% vs 2024 (€ 242,371) Unchanged	▼ 9%

Key figures of Bioresolutions, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Bioresolutions?

What happened at Bioresolutions in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: loss of € 4,068. Source: NBB ↗
Dec 1, 2020 New establishment in Zulte. KBO
2020 JOKE VANDESOMPELE became a director. NBB
2020 ELLEN LEFEBVRE became a director. NBB
Dec 1, 2020 Start of the company according to the CBE. KBO

In short

From € 71,756 profit in 2022 to € 4,068 loss in 2025.

Paid € 20,450 in corporate taxes since 2022.

Best year ever: 2022, with € 71,756 profit.

Paid out € 20,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JOKE VANDESOMPELE ELLEN LEFEBVRE

INACTIV BLUE

Bioresolutions

Behind Bioresolutions are JOKE VANDESOMPELE and ELLEN LEFEBVRE. JOKE VANDESOMPELE is also behind INACTIV BLUE.

Directors

According to the 2025 annual accounts

JOKE VANDESOMPELE

Director

Also active at: INACTIV BLUE

since 2020

ELLEN LEFEBVRE

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Kruishoutemstraat 57

9870 Zulte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0758.934.037

VAT number

BE 0758.934.037

Registered office

Kruishoutemstraat 57, 9870 Zulte

Names & denominations

Bioresolutions

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 December 2020

Peppol

Active · Active since 27 Jul 2026

Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige zakelijke dienstverlening, neg

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

Bioresolutions

Warning lights

Financials

What happened to Bioresolutions?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions